Patients with chronic cough reported autonomic symptoms with substantially increased frequency and severity when compared with a healthy control population.
A study revealed that chronic cough, thought to be a neuronal hypersensitivity disorder, is linked with more frequent and severe autonomic symptoms. The results were published in ERJ Open Research.
This finding is in accordance with previous observations that patients with similar neuronal hypersensitivity disorders experience increased autonomic symptoms.
Patients with chronic cough can cough upwards of thousands of times a day. Coughing episodes stimulate the autonomic nervous system, which results in raised blood pressure and heart rate. Protracted coughing can lead to a desensitization of the autonomic system, which can subsequently lead to sympathetic dominance, autonomic imbalance, and autonomic dysfunction.
Although previous associations have been found between autonomic dysfunction and conditions characterized by neuronal/visceral hypersensitivity such as irritable bowel syndrome, fibromyalgia, and complex regional pain syndrome, this is the first study of its kind to investigate whether patients with chronic cough experience increased autonomic symptoms, the authors said.
In their study, investigators recruited 96 patients with chronic cough and 76 healthy controls from a hospital in Manchester in the United Kingdom. Participants completed the Composite Autonomic Symptom Score (COMPASS) 31 autonomic symptom questionnaire to measure self-reported autonomic symptoms and functions and results were compared between the patient population and the age- and gender-matched healthy control population.
The COMPASS questionnaire scored symptoms across 6 areas: orthostatic intolerance, vasomotor, secretomotor, gastrointestinal, bladder, and pupillomotor.
Participants also completed the Cough Quality of Life Questionnaire (CQLQ) to measure the impact of cough on daily life, and a cough severity visual analogue (VAS) scale to measure cough severity. Associations between the COMPASS questionnaire and the 2 subsequent measurement instruments were observed.
Findings showed:
The study findings indicated that patients with chronic cough experienced autonomic symptoms with substantially increased frequency and severity than healthy volunteers, suggesting that this population may be subject to autonomic dysfunction. These symptoms were predominantly observed in parasympathetically mediated systems. Whether a patient’s cough causes this effect, or if both the cough and dysfunction are part of a wider vagal pathology, is unclear and requires further investigation, the authors said.
Reference
Dockry RJ, Farrelly CL, Mitchell J, Corfield DR, Smith JA. Chronic cough is associated with increased reporting of autonomic symptoms. ERJ Open Res. 2021;7(3):00105-2021. doi:10.1183/23120541.00105-2021
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Study Reveals Link Between Ovarian Cancer, Subsequent Dry Eye Disease Incidence
May 13th 2024Patients diagnosed with ovarian cancer (OC), particularly those older than 60 years or with a disease duration exceeding 5 years, had a higher incidence of subsequent dry eye disease (DED), suggesting a potential correlation between OC and DED.
Read More
Persistence Pays Off With Zanubrutinib: A Challenging CLL Case With a Prior BTK Inhibitor Failure
May 10th 2024The case of a 77-year-old woman with a long chronic lymphocytic leukemia (CLL) history illustrates the novel use of zanubrutinib as a potential option for some patients who have failed first-generation Bruton tyrosine kinase (BTK) inhibitors and venetoclax.
Read More
Research Shows Prior Authorization Denials Delay Critical Immunology Care
May 10th 2024Results featured at the Academy of Managed Care Pharmacy 2024 annual meeting revealed a pattern of prior authorization rejections that could delay necessary therapeutic treatments for various patient groups.
Read More